Biological Information
Background Information:
The BioMAP Oncology Early Screening Service (VascHT29) is a high quantity screening format in BioMAP oncology system VascHT29, comprised of peripheral blood mononuclear cells, the HT-29 colorectal adenocarcinoma cell line, and venular endothelial cells. This vascular TME model is stimulated via the T cell receptor for 48 hrs to recapitulate the activation of tumor infiltrating immune cells in the context of an immunosuppressive cancer cell line and normal host vascular tissue. Biomarker readouts capture impacts on translationally relevant immune, angiogenesis, and inflammation related intertumoral responses. This service allows for rapid testing of 18 compounds at 4 concentrations for immuno-oncology potential in human tumor microenvironment models.
Organism:
Human
Assay Information
Assay Type:
Functional
Assay Sub Type:
Cell Based
Testing Information
Test Sample Requirements:
For Small Molecules, 50 ul of 1000X stock solution in 100% DMSO per agent. For Biologics, 500 ul of 100X stock solution in PBS or water per agent.
Minimum Order Quantity:
72
Turnaround Time
Standard:
30 Business Days
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Additional Information
Brand:
BioMAP
Testing Location:
USA - St Charles, MO
RELATED SOLUTIONS